Expression of p53 & epidermal growth factor receptor in glioblastoma

被引:7
|
作者
Karnam, Sameera
Kottu, Radhika [1 ]
Chowhan, Amit Kumar
Bodepati, Prasad Chandramouleswara
机构
[1] Sri Venkateswara Inst Med Sci, Dept Pathol, Alipiri Rd, Tirupati 517507, Andhra Pradesh, India
关键词
Epidermal growth factor receptor; glioblastoma; immunohistochemistry; p53; ASTROCYTOMA PROGRESSION; GENE AMPLIFICATION; MULTIFORME; MUTATIONS; PROTEIN; EGFR; HETEROZYGOSITY; CLASSIFICATION; POPULATION; PATHWAYS;
D O I
10.4103/ijmr.IJMR_1179_15
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background & objectives: Glioblastoma (GB) is the most frequent brain tumour, manifesting at any age, with a peak incidence between 45 and 75 years. Primary and secondary GBs constitute relatively distinct disease entities in evolution, in expression profiles and in therapeutic response. Histopathologically, primary and secondary GBs are indistinguishable. The aim of this investigation was to study the immunohistochemical (IHC) expression of p53 and epidermal growth factor receptor (EGFR) in GB with the objective of categorizing the morphological variants of GB into primary and secondary based on the presence of low-grade areas and knowing the variable expression of p53 and EGFR in primary and secondary GB. Methods: A total of 28 patients with GB were studied and categorized into primary and secondary based on the presence of low-grade areas, i.e. discernible astrocytic morphology, gemistocyte and oligodendroglia. Tumours with the presence of combination of the above features or any one of the above features were taken as secondary GB, whereas tumours with highly pleomorphic areas were considered as primary GB. IHC was done on the representative tissue blocks for p53 and EGFR. Results: Majority of the patients were in the fifth and sixth decades of life with a mean age of 46.96 +/- 13 yr with male preponderance (male:female 2.5:1). Mean age of presentation was 48.93 +/- 12 yr in primary and 44.69 +/- 15 yr in secondary GB. All cases of GB were classified into primary (53.57%) and secondary (46.43%) based on morphology. EGFR was more frequently expressed than p53. Based on IHC, 50 per cent of cases were classified into primary, three per cent into secondary and 47 per cent as unclassified. Interpretation & conclusions: Histopathological features, i.e. presence of low-grade areas, may play a role in classifying GB into primary and secondary. EGFR has a pivotal role in gliomagenesis. Combination of p53 and EGFR alone may not be sufficient to clarify GB into primary and secondary.
引用
收藏
页码:738 / 745
页数:8
相关论文
共 50 条
  • [21] Notch-1 regulates transcription of the epidermal growth factor receptor through p53
    Purow, Benjamin W.
    Sundaresan, Tilak K.
    Burdick, Michael J.
    Kefas, Benjamin A.
    Comeau, Laurey D.
    Hawkinson, Michael P.
    Su, Qin
    Kotliarov, Yuri
    Lee, Jeongwu
    Zhang, Wei
    Fine, Howard A.
    CARCINOGENESIS, 2008, 29 (05) : 918 - 925
  • [22] Clinical Significance of Serum p53 and Epidermal Growth Factor Receptor in Patients with Acute Leukemia
    Abdel-Aziz, Mohamed Mohamed
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (07) : 4295 - 4299
  • [23] Epidermal Growth Factor Receptor (EGFR) and p53 co-expression in Head and Neck Squamous Cell Carcinomas (SCC)
    Balica, A. R.
    Boia, E.
    Gaje, P. N.
    Cimpean, A. M.
    Raica, M.
    VIRCHOWS ARCHIV, 2015, 467 : S88 - S88
  • [24] EXPRESSION OF P53, C-ERBB-2 AND THE EPIDERMAL GROWTH-FACTOR RECEPTOR IN TRANSITIONAL CELL CARCINOMAS OF THE BLADDER
    WRIGHT, C
    MELLON, K
    JOHNSTON, P
    LANE, DP
    HARRIS, AL
    NEAL, DE
    HORNE, CHW
    JOURNAL OF PATHOLOGY, 1991, 163 (02): : A156 - A156
  • [25] EXPRESSION AND CLINICAL SIGNIFICANCE OF P53, O6-METHYLGUANINE-DNA METHYLTRANSFERASE AND EPIDERMAL GROWTH FACTOR RECEPTOR IN GLIOMA
    Fu, X. R.
    Sun, Z. C.
    Chang, Y.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2015, 29 (04): : 853 - 858
  • [26] Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles
    Hussein, Mahmoud R.
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2009, 87 (01) : 63 - 69
  • [27] Epidermal growth factor receptor and ligand family expression and activity in glioblastoma
    von Achenbach, Caroline
    Weller, Michael
    Szabo, Emese
    JOURNAL OF NEUROCHEMISTRY, 2018, 147 (01) : 99 - 109
  • [28] DJ-1 expression in glioblastomas shows positive correlation with p53 expression and negative correlation with epidermal growth factor receptor amplification
    Hinkle, David A.
    Mullett, Steven J.
    Gabris, Bethann E.
    Hamilton, Ronald L.
    NEUROPATHOLOGY, 2011, 31 (01) : 29 - 37
  • [29] Loss of p53 induces epidermal growth factor receptor promoter activity in normal human keratinocytes
    Bheda, A.
    Creek, K. E.
    Pirisi, L.
    ONCOGENE, 2008, 27 (31) : 4315 - 4323
  • [30] Mutant p53 Amplifies Epidermal Growth Factor Receptor Family Signaling to Promote Mammary Tumorigenesis
    Yallowitz, Alisha R.
    Li, Dun
    Lobko, Anthony
    Mott, Daniel
    Nemajerova, Alice
    Marchenko, Natalia
    MOLECULAR CANCER RESEARCH, 2015, 13 (04) : 743 - 754